During the UK Prime Minister Starmer's visit to China, CGTN's Guan Xin sat down with AstraZeneca CEO Pascal Soriot to discuss the company’s expanding strategy in China, including its newly announced $15 billion China investment during the visit. Soriot also outlined how AstraZeneca is engaging with China's innovation ecosystem as the country continues to open up its healthcare and lifesciences sectors.